These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 4583777

  • 1. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
    Myrvang B, Godal T, Ridley DS, Fröland SS, Song YK.
    Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
    Godal T, Myklestad B, Samuel DR, Myrvang B.
    Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.
    Job CK, Chacko CJ, Taylor PM, Daniel M, Jesudian G.
    Int J Lepr Other Mycobact Dis; 1976 Dec; 44(1-2):256-66. PubMed ID: 776862
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
    Godal T, Myrvang B, Samuel DR, Ross WF, Lofgren M.
    Acta Pathol Microbiol Scand Suppl; 1973 Dec; 236(0):45-53. PubMed ID: 4602874
    [No Abstract] [Full Text] [Related]

  • 5. Five cultivable mycobacterial strains giving blast transformation and leukocyte migration inhibition of leukocytes analogous to mycobacterium leprae.
    Mustafa AS, Talwar GP.
    Lepr India; 1978 Oct; 50(4):498-508. PubMed ID: 374869
    [No Abstract] [Full Text] [Related]

  • 6. Immune responses to mycobacterium leprae in man.
    Myrvang B.
    J Oslo City Hosp; 1975 Jan; 25(1):3-24. PubMed ID: 1092818
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of cell mediated immune responses in untreated cases of leprosy.
    Talwar GP, Krishnan AD, Mehra VL, Blum EA, Pearson JM.
    Clin Exp Immunol; 1972 Oct; 12(2):195-203. PubMed ID: 4567646
    [Abstract] [Full Text] [Related]

  • 8. Immune responsiveness to Mycobacterium leprae of healthy humans. Application of the leucocyte migration inhibition test.
    Myrvang B.
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):707-14. PubMed ID: 4611138
    [No Abstract] [Full Text] [Related]

  • 9. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
    Rada EM, Aranzazu N, Convit J.
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
    [No Abstract] [Full Text] [Related]

  • 10. Evidence that the mechanism of immunological tolerance ("central failure") is operative in the lack of host resistance in lepromatous leprosy.
    Godal T, Myrvang B, Froland SS, Shao J, Melaku G.
    Scand J Immunol; 1972 Dec; 1(4):311-21. PubMed ID: 4590279
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the antigenic specificity of Mycobacterium leprae. II. Purification and immunological characterization of the soluble antigen in leprosy nodules.
    Abe M, Minagawa F, Yoshino Y, Okamura K.
    Int J Lepr Other Mycobact Dis; 1972 Dec; 40(2):107-17. PubMed ID: 4119113
    [No Abstract] [Full Text] [Related]

  • 12. In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin.
    Bjune G.
    Clin Exp Immunol; 1979 Jun; 36(3):479-87. PubMed ID: 385182
    [Abstract] [Full Text] [Related]

  • 13. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy.
    Bullock WE, Fields JP, Brandriss MW.
    N Engl J Med; 1972 Nov 23; 287(21):1053-9. PubMed ID: 4562439
    [No Abstract] [Full Text] [Related]

  • 14. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ, Closs O, Belehu A.
    Int J Lepr Other Mycobact Dis; 1982 Dec 23; 50(4):455-67. PubMed ID: 6763003
    [Abstract] [Full Text] [Related]

  • 15. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1996 Sep 23; 64(3):257-67. PubMed ID: 8862259
    [Abstract] [Full Text] [Related]

  • 16. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U, Sinha S, Ramu G, Lamb J, Ivanyi J.
    Clin Exp Immunol; 1987 Apr 23; 68(1):58-64. PubMed ID: 3308210
    [Abstract] [Full Text] [Related]

  • 17. Leucocyte migration inhibition response of Mycobacterium habana with sensitized animals and cells from leprosy patients.
    Singh NB, Gupta HP, Mathur IS, Kumar A, Chakraborty SK.
    Indian J Lepr; 1985 Apr 23; 57(2):273-7. PubMed ID: 3935726
    [Abstract] [Full Text] [Related]

  • 18. [Correlation of skin tests and the production of gamma-interferon in leprosy patients].
    Suso L, Nogueira N, Vieira LM, Figueiredo AA, Porto JA, Sarno EN.
    Med Cutan Ibero Lat Am; 1988 Apr 23; 16(3):193-6. PubMed ID: 3143869
    [Abstract] [Full Text] [Related]

  • 19. Effect of circulating immune complexes of leprosy patients on leukocyte migration inhibition induced by Mycobacterium leprae antigens in healthy volunteers.
    Tyagi P, Girdhar BK, Katoch K, Sengupta V.
    Int J Lepr Other Mycobact Dis; 1991 Sep 23; 59(3):487-92. PubMed ID: 1890375
    [No Abstract] [Full Text] [Related]

  • 20. The effect of Mycobacterium leprae on PHA- and PPD-induced inhibition of leukocyte migration in leprosy patients.
    Dharma Rao T, Lakshmana Rao SS, Rajan R, Rao PR.
    Lepr Rev; 1985 Jun 23; 56(2):109-16. PubMed ID: 3894846
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.